Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof
US11525005B2 · kind B2 · utility
0Cited by
2References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 31, 2018 |
| Grant date | Dec 13, 2022 |
| Priority date | — |
| Expiry date | Aug 8, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are an anti-CD40 antibody, an antigen binding fragment thereof, and a medical use thereof. Also provided are a chimeric antibody and a humanized antibody including a CDR region of the anti-CD40 antibody, a pharmaceutical composition including the human anti-CD40 antibody and the antigen binding fragment thereof, and an application thereof as an anti-cancer drug. In particular, provided are a humanized anti-CD40 antibody, and an application thereof in preparation of a drug to treat a CD40-mediated disease or disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.